Skip to content

Ayurvedic management of Vandhyatva (female infertility) due to anovulatory factor associated with obesity

Efficacy of Virechana Karma, Lashunadi Taila Matra Basti along with Guduchi-Mustadi Kashaya orally in the management of Vandhyatva (Female Infertility) due to anovulatory factor associated with obesity: A single arm open labelled clinical trial - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064311
Enrollment
20
Registered
2024-03-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N970- Female infertility associated withanovulation

Interventions

None listed

Sponsors

Institute of Teaching and Research in Ayurveda, Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to give written informed consent by themselves. Infertile female patients of reproductive age more than or equal to 20 years and less than or equal to 40 years. Patients who have age less than 35 years completed active married life of minimum 1 year duration and patients aged 35 years or more completed active married life of 6 months suffering from Infertility with 2 or more consecutive anovulatory cycles. Patients having class I obesity - overweight (BMI 25.0-29.9 kg/m2), class II obesity - obesity (BMI 30.0-39.9 kg/m2). Primary and secondary infertile patients having anovulatory cycle or immature ovarian follicle. Patient eligible & willing for Virechana Karma and Matra Basti.

Exclusion criteria

Exclusion criteria: Patients with infectious diseases of the reproductive tract like tuberculosis and sexually transmitted diseases. Organic lesions of the reproductive tract like carcinoma and congenital deformities. Patients with history of cardiac diseases, Uncontrolled Diabetes (above 200 mg/dl- RBS) & Hypertension (Systolic BP above 160 & Diastolic above 100mmhg), etc. Patients with Hepatitis C, Hepatitis B. Patients are not eligible for Virechana Karma and Matra Basti.

Design outcomes

Primary

MeasureTime frame
It is expected that the trial protocol will induce ovulation. It is expected that trial protocol will help to reduce the BMI of patient. Timepoint: 3 months

Secondary

MeasureTime frame
Trial protocol will cure menstrual abnormalities associated with anovulation like irregular, scanty/ excessive menstruation and dysmenorrhea. Improvement in quality of life. Timepoint: 3 months

Countries

India

Contacts

Public ContactDr Shilpa B Donga

Institute of Teaching and Research in Ayurveda, Jamnagar

drshilpadonga@yahoo.com9825646796

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026